Abstract: A composition for use as a film layer comprises (A) an olefin-based polymer having a volume resistivity greater than 5.0*1015 ohm·cm; (B) a hydrophilic fumed silica; (C) an alkoxysilane; (D) an organic peroxide; and, optionally, (E) from 0 wt % to 1.5 wt % of a crosslinking co-agent.

Abstract: A platinum sulfide protein nanoparticle having near-infrared photothermal effect and multi-modal imaging function, a preparation method therefor and an application thereof. The platinum sulfide nanoparticle having near-infrared photothermal effect and multi-modal imaging function is prepared in aqueous phase by means of formulation screening and process limitation. The nanoparticle has an ultra-small particle size and good stability as well as tumor targeting and photothermal effects and integrates functions of near-infrared imaging, CT imaging, and thermal imaging, so as to achieve high sensitivity, high resolution, and precise positioning of tumors, and to produce high-efficiency photothermal effects under the excitation of near-infrared light to kill tumor cells by thermal ablation, thereby achieving the purpose of efficient, safe, visual, and accurate treatment of tumors. The nanoparticle has the potential for further development and clinical application.

Abstract: Embodiments of the present application provide a method for controlling voltages of a liquid crystal on silicon (LCoS) two-dimensional array which includes a plurality of pixel sets, and the plurality of pixel sets include a first pixel set and a second pixel set. The method includes: determining a plurality of bit sequences, where the plurality of bit sequences include a first bit sequence and a second bit sequence; controlling a voltage of the first pixel set by using the first bit sequence; and controlling a voltage of the second pixel set by using the second bit sequence, where the first pixel set and the second pixel set are in different phase cycles in a port direction of the LCoS two-dimensional array, the first pixel set and the second pixel set have a same phase, and duty ratios of the first bit sequence and the second bit sequence are the same.

Abstract: The invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS symptoms in a mammal using compounds of Formula I.

Abstract: An elbow joint rehabilitation system and an elbow joint rehabilitation method are provided. The elbow joint rehabilitation system includes a support member, a motor, a torque sensing unit, a first electromyography sensor, a second electromyography sensor and a motor control device. In the elbow joint rehabilitation method, the support member is configured to support an arm of a patient. Thereafter, the torque sensing unit is configured to sense the torque applied on the support member to obtain a sensed arm torque signal. Then, the first electromyography sensor and the second electromyography sensor are configured to sense the muscle activities of biceps and triceps of the patient to obtain electromyography signals. Thereafter, the motor is controlled to drive the support member to perform rehabilitation in accordance with the sensed arm torque signal, the electromyography signals and a current support member position provided by the motor.

Abstract: A method of producing a non-erythroid protein in erythrocytes of a transgenic animal using an erythroid-specific promoter includes synthesizing an erythroid-specific globin gene promoter and globin gene locus control region and cloning the promoter and the globin gene locus control region and a gene encoding a non-erythroid protein into a vector to obtain a transgene; introducing the transgene in pronuclear embryos collected from a mammalian animal in vitro; transplanting the pronuclear embryos containing the transgene into oviduct of a female recipient of the mammalian animal to obtain a transgenic animal which then expresses the non-erythroid protein in progenitor cells of erythrocytes; and collecting blood from the transgenic animal and isolating the non-erythroid protein from the erythrocytes.

Abstract: A surgical instrument inventory system, including a memory and a processor, is provided. The memory is configured to store a global identification module and a local identification module. The processor is coupled to the memory and is configured to input a surgical instrument image to the global identification module and the local identification module. The global identification module is configured to output multiple global image features corresponding to the surgical instrument image. The local identification module is configured to output multiple local image features corresponding to an instrument end image of the surgical instrument image. The processor determines a surgical instrument type of the surgical instrument image according to the multiple global image features and the multiple local image features.

Abstract: The present disclosure provides a pellet. In an embodiment, the pellet includes a body having a first end and an opposing second end. The body is composed of a polymeric material. The body has a length and a diameter (body diameter). A channel having a diameter (channel diameter), extends through the body from the first end to the second end. The pellet has a channel diameter-to-body diameter ratio from 0.05 to 0.45. The present disclosure also provides a process for soaking the pellet in a liquid additive and forming a loaded pellet with the additive in the pellet body.

Abstract: An automatic control method of a mechanical arm and an automatic control system are provided. The automatic control method includes the following steps: obtaining a color image and depth information corresponding to the color image through a depth camera; performing image space cutting processing and image rotation processing according to the color image and the depth information to generate a plurality of depth images; inputting the depth images into an environmental image recognition module such that the environmental image recognition module outputs a displacement coordinate parameter; and outputting the displacement coordinate parameter to a mechanical arm control module such that the mechanical arm control module controls the mechanical arm to move according to the displacement coordinate parameter.

Abstract: An LED package structure and a carrier thereof are provided. The LED package structure includes a carrier, a plurality of LED chips, and an encapsulating colloid. The carrier includes a substrate, a ring-shaped first wall disposed on the substrate, and a ring-shaped second wall stacked on the first wall. A portion of the substrate surrounded by the first wall is defined as a die-bonding region, and the first wall, the second wall, and the die-bonding region jointly define an accommodating space. The LED chips are mounted on the die-bonding region and are arranged in the accommodating space. The encapsulating colloid is filled within the accommodating space, and the LED chips are embedded in the encapsulating colloid.

Abstract: A detachable partition assembly includes a main plate body, a first engaging portion, a second engaging portion, and a first rail. The main plate body has a first edge and a second edge opposite to each other. The first engaging portion and the second engaging portion respectively protrude outwards from the first edge and the second edge. The first rail is located at a side of the main plate body and adjacent to the second engaging portion. The first rail is movably disposed on the main plate body to change a relative position between the first rail and the second edge.

Abstract: Compounds for use in treating or preventing human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof. Methods associated with the preparation and use of the disclosed compounds, as well as pharmaceutical compositions comprising such compounds are also disclosed.

Abstract: A semiconductor device, and methods of forming the same. In one example, the semiconductor device includes a trench in a substrate having a top surface, and a shield within the trench. The semiconductor device also includes a shield liner between a sidewall of the trench and the shield, and a lateral insulator over the shield contacting the shield liner. The semiconductor device also includes a gate dielectric layer on an exposed sidewall of the trench between the lateral insulator and the top surface. The lateral insulator may have a minimum thickness at least two times thicker than a maximum thickness of the gate dielectric layer.

Abstract: Disclosed are methods of using liquid polymer and inverse emulsion compositions comprising one or more hydrophobic liquids having a boiling point at least about 100° C.; one or more acrylamide-(co)polymers; one or more emulsifier surfactants; one or more inverting surfactants; and one or more stabilizing agents (e.g., one or more siloxane polyether compounds, one or more poly(alkyl)acrylate compounds, or any combination thereof). When the composition is inverted in an aqueous solution, it provides an inverted solution having a filter ratio using a 1.2 micron filter (FR1.2) of about 1.5 or less. The inverted solutions can be used in oil and gas operations.

Abstract: Incidents involving confidentiality and vigilance against user privacy invasions raise doubts as to current third-party data collection procedures. Personally identifiable information (PII) is being abused for medical data breaches, identity theft, spam, phishing, cyber spying, etc. A great amount of data is flowing from users to companies for prediction and analysis of data-centric markets. It is thus difficult to track PII flow and genuineness. Blockchain technology, which is an “immutable” distributed ledger, can efficiently track PII exchange, storing, and distribution. In contrast, the EU general data protection regulation (GDPR) in progress claims “a right to forget” and a right “to delete”. However, the present specification proposes an off-chain blockchain architecture using both a local database and a distributed ledger to guarantee a trustable PII life cycle.

Abstract: Anti-tumor platinum drug mineralized protein nanoparticles and a preparation method therefor are disclosed. The anti-tumor platinum-based drug mineralized protein nanoparticles include a platinum drug and a protein. The protein is one or more selected from the group consisting of albumin, transferrin, hemoglobin, and low-density lipoprotein. The platinum drug is cisplatin, iodoplatin, bromoplatin, oxaliplatin, carboplatin, or nedaplatin. A drug loading of the anti-tumor platinum-based drug mineralized protein nanoparticles is 1% to 50%.

Abstract: Provided herein are liquid polymer (LP) compositions comprising an acrylamide (co)polymer, as well as methods for preparing inverted polymer solutions by inverting these LP compositions in an aqueous fluid. The resulting inverted polymer solutions can have a concentration of acrylamide (co)polymer of from about 50 to about 15,000 ppm, and a filter ratio of 1.5 or less at 15 psi using a 1.2 ?m filter. Also provided are methods of using these inverted polymer solutions in dewatering, clarification, flocculation and/or thickening applications, and the like.

Abstract: A semiconductor device has a semiconductor material in a substrate. The semiconductor device has an MOS transistor. A trench in the substrate extends from a top surface of the substrate) into the semiconductor material. A shield is disposed in the trench. The shield has a contact portion which extends toward a top surface of the trench. A gate of the MOS transistor is disposed in the trench over the shield. The gate is electrically isolated from the shield. The gate is electrically isolated from the contact portion of the shield by a shield isolation layer which covers an angled surface of the contact portion extending toward the top of the trench. Methods of forming the semiconductor device are disclosed.

Abstract: The present disclosure concerns methods of using novel bacterial strains of 0617-T307, 0917-T305, 0917-T306, 0917-T307, 0118-T319, 0318-T327, and 0418-T328, the cell broth and novel metabolites produced from the bacterial strains, that can inhibit the growth of a variety of microbial species for a variety of crops.

Abstract: The present disclosure concerns methods of using novel bacterial strains of 0617-T307, 0917-T305, 0917-T306, 0917-T307, 0118-T319, 0318-T327, and 0418-T328, the cell broth and novel metabolites produced from the bacterial strains, that can inhibit the growth of a variety of fish pathogens.